Kane Biotech Inc.

Kane Biotech Inc.

KNBIF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.8M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Kane Biotech Inc.Kane Biotech Inc.-2.1-272%--2

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.80 Million
Enterprise Value$5.91 Million
Earnings per Share$-0.02
Beta0.31
Outstanding Shares205,056,565

Return

Return on Equity271.82%ROE
Return on Assets-121.24%
Return on Invested Capital951.36%

Valuation & Multiples

P/E Ratio-2.05P/E Ratio
PEG-1.48PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.02Price to Book Ratio
Enterprise Value to Revenue152.56
Enterprise Value to EBIT-1.86
Enterprise Value to Net Income-3
Total Debt to Enterprise0.33
Debt to Equity-1.98Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 27, 2026
EPS
-$0.00
Reported
Revenue
$5,732
Reported

Next Earnings Call

Expected Date
November 26, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Kane Biotech Inc.

20 employees
CEO: Robert Huizinga

Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse pro...